Navigation Links
Pitt receives $11 million from NIH to coordinate hepatitis B clinical research network
Date:1/29/2009

PITTSBURGH, Jan. 29 The National Institute of Diabetes and Digestive and Kidney Diseases has awarded a seven-year $11 million grant to the University of Pittsburgh Graduate School of Public Health to coordinate the Hepatitis B Clinical Research Network a consortium of 15 clinical and research centers in the U.S. and Canada that will conduct translational research on hepatitis B.

The network will include a multi-site treatment trial, create and maintain a large database of study results and store tissue and serum samples to facilitate clinical and basic research.

Hepatitis B is an infection that affects the liver. About 1.5 million Americans and 350 million people worldwide have chronic hepatitis B infection, which can lead to more serious diseases such as cirrhosis, liver failure and liver cancer.

"Medical advances have led to many treatments for chronic hepatitis B infection and most patients respond to them," said Steven Belle, Ph.D., principal investigator of the data coordinating center and professor of epidemiology, University of Pittsburgh Graduate School of Public Health. "However, these treatments do not cure the infection, but contain it by making it more difficult for the virus to reproduce."

Many patients need to stay on therapy for a long time, he added. And when treatment is prolonged, the virus can become resistant, making further treatment ineffective.

"We don't know why treatment works better for some patients than others, and we cannot accurately predict who may go on to develop liver abnormalities," said Dr. Belle. "But with the interdisciplinary expertise within the network, we hope to learn more about the immune changes that occur with hepatitis B infection and make inroads to finding a lasting cure."


'/>"/>

Contact: Clare Collins
CollCX@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1

Related medicine news :

1. ProAssurance Receives Regulatory Approvals for Transactions with the PICA Group and Georgia Lawyers Insurance Company
2. PEAK Surgical Receives European CE Mark for PEAK(R) Surgery System for Use in General Surgery
3. Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
4. UTSA receives federal funding for fossil fuel research
5. ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica
6. UTSA receives $1.2 million gift from Kleberg Foundation
7. IPC The Hospitalist Company Receives Best IPO Award from Los Angeles Venture Association
8. Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
9. YMCA of Greater Pittsburgh Receives $500,000 from McAuley Ministries for New Hill YMCA Roof
10. CORD:USE Cord Blood Bank Receives Prestigious Accreditation from the Foundation for the Accreditation of Cellular Therapy
11. MSU researcher receives $1.5 million grant for childhood obesity intervention study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... When MetLoop ... knew it was something that contractors should have at their disposal on a ... says Butch, CertainTeed’s Director of Contractor Programs. , As a result, Metloop ...
(Date:5/31/2016)... ... May 31, 2016 , ... The successful implementation of “lean manufacturing” in ... well. However, laboratories have different challenges compared to manufacturing environments. , In order ... lab, METTLER TOLEDO has developed the Lean Lab Checklist . This checklist will ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Spectrum Aquatics has ... new lift has been designed and built with the user in mind. , “Over ... consultants have informed us that an ADA 400 lbs lift is a necessary requirement ...
(Date:5/31/2016)... ... ... a recent interview on The Greenburgh Report radio show hosted by Greenburgh, NY Town ... leading medical insurance advocate Adria Goldman Gross discussed several eye-opening issues that have combined ... the interview with Mr. Feiner that aired on May 7, 2016, Ms. Gross, the ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... on patients with cancer, has added Cancer and Careers to its ... more timely content on continuing successful careers while fighting cancer. , As partners, ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... India , May 26, 2016 ... drugs market growth is the emergence of new treatments. ... astaxanthin therapies for osteoarthritis treatment. The therapy is expected ... Moreover, Arthritis Research UK is conducting studies to develop ... arcOGEN study, where the genes involved in osteoarthritis are ...
(Date:5/25/2016)... May 25,2016 FDA 510(k) ... Cellvizio platform for urological and surgical applications ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... in the US with the 12 th ... Administration (FDA). This new FDA clearance covers Confocal ...
Breaking Medicine Technology: